你即將離開本站

並前往https://www.fiercebiotech.com/biotech/legend-s-status-put-hold-as-fda-delays-janssen-partnered-car-t-decision

Legend's status put on hold as FDA delays Janssen-partnered ...

Legend Biotech and Johnson & Johnson have been hit by an FDA delay for their cell therapy blood cancer hopeful ciltacabtagene autoleucel.

確定！ 回上一頁

查詢 「Janssen」的人也找了：